Table: Mochida Pharm -2021/22 group results

Mochida Pharmaceutical

13/05/2022 06:00

May 13 (Reuters)- 
          Mochida Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          110.18          103.00         105.00                 
               (+7.0 pct)      (+1.2 pct)     (-4.7 pct)               
  Operating       14.39           12.00           8.50                 
               (+19.9 pct)     (+36.3 pct)    (-40.9 pct)              
  Recurring       14.80           12.26           8.80                 
               (+20.7 pct)     (+33.9 pct)    (-40.5 pct)              
  Net
  Net             10.57            8.59           6.40                 
               (+23.1 pct)     (+86.8 pct)    (-39.4 pct)              
  EPS          277.39 yen      222.29 yen     170.35 yen               
  Ann Div       90.00 yen       90.00 yen      80.00 yen               
  -Q2 Div       40.00 yen       40.00 yen      40.00 yen               
  -Q4 Div       50.00 yen       50.00 yen      40.00 yen               
  
  NOTE - Mochida Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T